arXivDaily arXiv每日学术速递 周一至周五更新
arXiv 2411.03361econ.GNq-fin.EC
收藏

年龄标准化睾酮水平在男性初创公司创始人的B轮融资时达到峰值

Age Normalized Testosterone Peaks at Series B for Male Startup Founders

Jordan Moradian, Michael Dubrovsky, Megha Sama, Pavel Korecky, Sidarth Kulkarni, Yaniv Goder, Diedrik Vermeulen

AI总结:

对107位Y Combinator男性创始人的研究发现,年龄标准化睾酮水平在B轮融资时达到峰值,支持双激素假说,并提示高睾酮创始人更易获得大额融资。

摘要:

在一项针对107位Y Combinator男性创始人的研究中,发现了年龄标准化睾酮水平与公司发展阶段之间令人惊讶的相关性。睾酮是一种与自信、支配欲和驱动力相关的激素,其水平从种子前融资到种子融资期间上升了55.7%,并在B轮融资阶段达到峰值,此时水平比种子前阶段高出99.6%。在B轮融资之后,观察到睾酮水平下降了42.2%,同时伴随着皮质醇水平的激增。这一年龄标准化的生物标志物分析支持了双激素假说,表明早期创业成功会培养支配感和自信心,而后期阶段的压力和紧张则会侵蚀这些感觉。对数据的另一种解读是,睾酮水平较高的男性创始人更有可能筹集到更大规模的融资轮次,这为进行纵向研究提供了机会。

英文摘要:

In a study of 107 male Y Combinator founders, a surprising correlation between age-normalized testosterone and company stage was uncovered. Testosterone, a hormone associated with confidence, dominance, and drive, increased by 55.7% from pre-seed to seed funding, peaking at the Series B stage, where levels were 99.6% higher than pre-seed. After series B funding, testosterone was observed to drop by 42.2%, coinciding with a spike in cortisol levels. This age-normalized biomarker analysis supports the dual-hormone hypothesis, illustrating that early startup success fosters feelings of dominance and confidence, while later-stage pressures and stresses erode these feelings. An alternative interpretation of the data, which suggests the opportunity for a longitudinal study, is that male founders with higher testosterone are more likely to raise larger rounds of funding.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑